首页> 外文期刊>Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research >Unique Review Criteria and Patient and Stakeholder Reviewers: Analysis of PCORI’s Approach to Research Funding
【24h】

Unique Review Criteria and Patient and Stakeholder Reviewers: Analysis of PCORI’s Approach to Research Funding

机译:独特的审查标准和患者和利益相关方评论者:PCORI研究资金的方法分析

获取原文
获取原文并翻译 | 示例
       

摘要

ObjectiveThe Patient-Centered Outcomes Research Institute (PCORI) uses a unique approach to Merit Review that includes patients and stakeholders as reviewers with scientists, and includes unique review criteria (patient-centeredness and active engagement of end users in the research).This study assessed the extent to which different reviewer types influence review scores and funding outcomes, the emphasis placed on technical merit compared to other criteria by a multistakeholder panel, and the impact of the in-person discussion on agreement among different reviewer types. MethodsCross-sectional analysis of administrative data from PCORI online and in-person Merit Review (N = 1312 applications from the five funding cycles from November 2013 to August 2015). Linear and logistic regression models were used to analyze the data. ResultsFor all reviewer types, final review scores were associated with at least one review criterion score from each of the three reviewer types. The strongest predictor of final overall scores for all reviewer types was scientists’ prediscussion ratings of technical merit. All reviewers’ prediscussion ratings of the potential to improve health care and outcomes, and scientists’ ratings of technical merit and patient-centeredness, were associated with funding success. For each reviewer type, overall impact scores from the online scoring were changed on at least half of the applications at the in-person panel discussion. Score agreement across reviewer types was greater after panel discussion. ConclusionsScientist, patient, and stakeholder views all contribute to PCORI Merit Review of applications for research funding. Technical merit is critical to funding success but patient and stakeholder ratings of other criteria also influence application disposition.
机译:象征患者以患者为中心的结果研究所(PCORI)使用独特的方法来审查,其中包括患者和利益相关者作为科学家的审稿人,包括独特的审查标准(患者中心和最终用户的积极参与研究)。这项研究评估不同审稿人类型影响审查分数和资金成果的程度,与多利益相关方专家组的其他标准相比,对技术优点的重点,以及对不同审核类型的讨论对达成协议的影响。 Folums-PCORI在线和人员优异评论的行政数据分析(N = 1312次资金周期从2013年11月到2015年8月)。线性和逻辑回归模型用于分析数据。结果所有审阅者类型,最终审查分数与来自三种评论员类型中的每一个的至少一个审查标准分数相关联。所有审稿人类型的最终总数的最强预测因子是科学家的技术优点的预测评级。所有审查人员的预测评级有可能改善医疗保健和结果,以及科学家的技术优点和患者中心的评级,与资金取得有关。对于每个审阅者类型,在线评分的总体影响分数在本领域讨论中的至少一半申请中更改。在小组讨论后,审阅者类型的评分协议更大。结论科学家,患者和利益相关者的意见所有促进了研究资金申请的PCORI Merit审查。技术优点对于融资成功至关重要,但患者和利益相关者其他标准的评级也会影响申请性格。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号